Inoviv
|
Year Established:
2018 |
|
|
Website:
inoviv.com |
|
|
Headquarters:
London, , GB |
|
|
Company Type:
Small Business (1-10M TTM Revenue) |
Inoviv, a leading biotechnology company, uses advanced LC-MS-based quantitative proteomics to enhance the biopharma R&D pipeline. Advised by top clinical academics (University of Oxford, University of Luxembourg), Inoviv operates from GLP/GCP-certified labs in the UK and US.
The company supports pre-clinical and clinical studies in Europe and the US with biomarker discovery and targeted assay development. Our multiplexed assays, suitable for regulatory submissions, generate treatment efficacy data, demonstrate target engagement, and identify patient responders. Inoviv’s targeted proteomics and lipidomics assays monitor neurodegeneration, COVID-19, rare diseases, and more.
| Site | Badges | |
|---|---|---|
| Headquarters - London 136 High Holborn London, , WC1V 6PX United Kingdom | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.